NTRA - Natera, Inc.
IEX Last Trade
159.94
0.365 0.228%
Share volume: 14,340
Last Updated: Fri 27 Dec 2024 08:30:02 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$159.58
0.37
0.23%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-06 | 2022-08-05 | 2022-11-09 | 2023-03-01 | 2023-05-10 | 2023-08-04 | 2023-11-09 | 2024-02-29 | |
| Assets | |||||||||
| Total Assets | 1.145 B | 1.067 B | 1.009 B | 1.394 B | 1.319 B | 1.248 B | 1.447 B | 1.442 B | |
| Current Assets | 980.226 M | 901.555 M | 829.629 M | 1.212 B | 1.129 B | 1.066 B | 1.267 B | 1.259 B | |
| Inventories | 25.048 M | 30.465 M | 40.428 M | 35.406 M | 40.683 M | 42.688 M | 42.076 M | 40.759 M | |
| Other Current Assets | 35.130 M | 24.041 M | 31.599 M | 33.634 M | 29.988 M | 26.818 M | 33.496 M | 60.524 M | |
| Short Term Investments | 35.130 M | 24.041 M | 31.599 M | 33.634 M | 29.988 M | 26.818 M | 33.496 M | 60.524 M | |
| Total Receivables | 167.862 M | 208.312 M | 236.362 M | 244.385 M | 246.785 M | 260.065 M | 255.147 M | 278.289 M | |
| Current Cash | 751.958 M | 638.651 M | 521.154 M | 898.306 M | 812.012 M | 735.941 M | 936.557 M | 878.977 M | |
| Total Non-current Assets | 164.438 M | 165.421 M | 179.483 M | 182.657 M | 189.412 M | 182.381 M | 179.244 M | 183.150 M | |
| Property Plant Equipment | 78.361 M | 81.772 M | 87.486 M | 92.453 M | 100.587 M | 102.921 M | 104.830 M | 111.210 M | |
| Other Assets | 21.676 M | 21.502 M | 18.206 M | 18.330 M | 19.288 M | 17.518 M | 16.208 M | 15.403 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.145 B | 1.067 B | 1.009 B | 1.394 B | 1.319 B | 1.248 B | 1.447 B | 1.442 B | |
| Total liabilities | 602.329 M | 622.394 M | 647.491 M | 688.730 M | 668.307 M | 651.746 M | 661.862 M | 676.372 M | |
| Total current liabilities | 231.072 M | 251.618 M | 267.281 M | 310.499 M | 290.969 M | 276.856 M | 289.923 M | 307.274 M | |
| Accounts Payable | 18.070 M | 28.192 M | 34.225 M | 31.148 M | 36.123 M | 21.107 M | 21.321 M | 14.998 M | |
| Other liabilities | 23.074 M | 24.339 M | 20.405 M | 20.001 M | 21.511 M | 21.502 M | 21.033 M | 19.128 M | |
| Current long term debt | 50.055 M | 50.086 M | 50.147 M | 80.350 M | 80.398 M | 80.418 M | 80.435 M | 80.402 M | |
| Long term debt | 280.706 M | 281.020 M | 281.336 M | 281.653 M | 281.973 M | 282.295 M | 282.619 M | 282.945 M | |
| Other liabilities | 23.074 M | 24.339 M | 20.405 M | 20.001 M | 21.511 M | 21.502 M | 21.033 M | 19.128 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 542.335 M | 444.582 M | 361.621 M | 705.744 M | 650.573 M | 596.147 M | 784.658 M | 765.327 M | |
| Common stock | 95.578 M | 96.579 M | 97.052 M | 104.423 M | 111.767 M | 113.690 M | 115.171 M | 119.360 M | |
| Retained earnings | -1.533 B | -1.679 B | -1.800 B | -1.943 B | -2.080 B | -2.190 B | -2.299 B | -2.377 B |